STOCK TITAN

Heska to Participate in the 41st J.P. Morgan Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

LOVELAND, Colo., Dec. 23, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska's management team will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Kevin Wilson, Heska's President & Chief Executive Officer, will present on Wednesday, January 11, 2023 at 9:45 a.m. Pacific Standard Time. A live audio webcast of Mr. Wilson's presentation will be available by visiting Heska J.P. Morgan 2023 Healthcare Conference Webcast. The webcast and presentation will be archived on the Company's website shortly after the event and a replay will be available for 90 days following the conference.

Mr. Wilson and members of Company management will also be participating in one-on-one meetings on January 11th. To request a meeting, please contact J.P. Morgan at 1x1@jpmorgan.com or Heska Investor Relations at investorrelations@heska.com.

For more information regarding the J.P. Morgan 2023 Healthcare Conference, visit J.P. Morgan Healthcare Conference Website.

About Heska

Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostics, informatics, and specialty healthcare solutions through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production for third-parties, primarily for herd animal health. For more information, please visit www.heska.com.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-to-participate-in-the-41st-jp-morgan-annual-healthcare-conference-301708831.html

SOURCE Heska Corporation

HSKA

NASDAQ:HSKA

HSKA Rankings

HSKA Latest News

HSKA Stock Data

1.31B
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Loveland

About HSKA

heska corporation (nasdaq: hska) is dedicated to perfecting and supporting the core technology and services that truly impact the quality of pet care and help to ensure positive outcomes for veterinarians and their patients. heska was created by veterinary professionals for veterinary professionals. our pledge to customers is to stand behind sound science, following best medical practices. heska’s line of diagnostic and imaging advancements include state-of-the-art chemistry, hematology, and blood gas & electrolyte systems, as well as single-step heartworm, early renal healthscreens, allergy testing and allergy treatment. heska also leads the way with the latest hd digital radiography, digital ultrasound, and pacs imaging technologies from cuattro. we help veterinary practices discover the right product solutions for their clients and patients; improving patient care, productivity and profitability. heska’s corporate headquarters are in loveland, colorado. we provide our products a